ALTAMIR (LTA) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: 3.96%
• Average Volume (3M): 20.42K
• Price to Earnings (P/E): 52.0
• Beta (1Y): 0.01
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: FR
• Employees: N/A
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): N/A
• Shares Outstanding: 36,512,302
• 10 Day Avg. Volume: 3,305
• 30 Day Avg. Volume: 20,419
• PEG Ratio: -1.30
• Price to Book (P/B): 0.64
• Price to Sales (P/S): 11.34
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 59 Neutral
• Price Target: ―

ALTAMIR's overall score reflects a balance of mixed financial performance with challenges in revenue and cash flow, neutral technical analysis, and a high valuation. While the company's equity stability and dividend yield provide some strengths, the high P/E ratio and recent technical weakness weigh on the stock's attractiveness.

ALTAMIR Business Overview & Revenue Model

Company Description

Altamir SCA formerly known as Altamir Amboise, is a private equity firm specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments. The firm typically invests in the following sectors: healthcare, TMT, digital companies, services, retail and distribution. It also invests in retail and consumer, business and financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between €50 million ($55.36 million) and €500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between €500 million ($553.60 million) and €3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. It invests and disinvests with the private equity funds of Apax Partners France and Amboise Investissement under the same conditions and also invests directly in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm seeks to exit its investments within five years. It makes balance sheet investments. Altamir SCA was founded in 1995 and is based in Paris, France.

How the Company Makes Money

ALTAMIR makes money primarily through capital appreciation and income generation from its portfolio of investments. The company invests in private equity funds managed by Apax Partners, which target high-growth potential companies. Revenue is generated when these portfolio companies are sold at a profit or through dividends and interest from investments. ALTAMIR also benefits from management fees and carried interest associated with its investments, as well as strategic partnerships with other financial institutions that enhance deal flow and investment opportunities.

ALTAMIR Financial Statement Overview

Summary

ALTAMIR presents a mixed financial health picture. Despite maintaining positive net income and strong equity stability, the company faces challenges with revenue decline and cash flow inconsistencies.

Income Statement

ALTAMIR's revenue has shown a declining trend over the years, with a significant drop from 2019 to 2024. However, the company has managed to maintain positive net income in recent years, indicating improved operational efficiency. The gross profit margin has decreased, impacting overall profitability.

Balance Sheet

The company's balance sheet demonstrates strong equity stability, with a high equity ratio indicating solid backing by stockholders. The debt-to-equity ratio remains low, suggesting manageable leverage levels. Nonetheless, fluctuations in total assets and liabilities could suggest potential risk factors.

Cash Flow

Cash flow analysis reveals inconsistencies, with negative free cash flow in recent years and operating cash flow issues. These challenges may impact the company's liquidity and operational capacity. However, prior years showed strong cash flow management.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	72.70M	3.25M	52.52M	104.66M	157.37M
Gross Profit	30.20M	32.56M	39.91M	93.63M	129.10M
EBITDA	32.45M	34.77M	-10.57M	311.88M	191.21M
Net Income	18.80M	28.25M	-26.95M	291.95M	139.10M
Balance Sheet
Total Assets	1.68B	1.41B	1.42B	1.45B	1.36B
Cash, Cash Equivalents and Short-Term Investments	35.20M	21.60M	146.39M	188.89M	76.81M
Total Debt	238.50M	59.01M	57.82M	26.01M	98.12M
Total Liabilities	397.50M	112.71M	103.19M	69.09M	232.35M
Stockholders Equity	1.28B	1.30B	1.31B	1.38B	1.13B
Cash Flow
Free Cash Flow	61.47M	-92.80M	-28.60M	-44.99M	-66.15M
Operating Cash Flow	61.47M	-92.80M	-28.60M	-44.99M	-66.15M
Investing Cash Flow	0.00	0.00	0.00	216.53M	0.00
Financing Cash Flow	-53.40M	-31.29M	-37.21M	-53.99M	44.28M

ALTAMIR Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 27.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LTA, the sentiment is Neutral. The current price of 27 is above the 20-day moving average (MA) of 26.42, below the 50-day MA of 27.19, and above the 200-day MA of 25.43, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 50.07 is Neutral, neither overbought nor oversold. The STOCH value of 87.57 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:LTA.

ALTAMIR Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PEUG	75 Outperform	€1.83B	45.92	0.83%	4.43%	-48.21%	-64.53%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
MF	66 Neutral	€3.50B	11.68	-2.85%	5.98%	9.86%	-118.70%
TKO	61 Neutral	€3.19B	17.55	5.94%	4.38%	12.44%	12.15%
LTA	59 Neutral	―	52.01	―	3.96%	―	―
RF	49 Neutral	€4.27B	―	-8.86%	4.55%	11.76%	-735.88%